A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

NCT03560882 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Malignant Disease
Solid Tumor
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Cancer
Relapsed Hematologic Malignancy

Interventions

DRUG: Atorvastatin

Sponsor

Joaquina Baranda